Publications by authors named "Frederick Ruberg"

Claim this Profile
C
Changes in Myocardial Light Chain Amyloid Burden After Plasma Cell Therapy.
Dominik C Benz, Olivier F Clerc, Sarah A M Cuddy, Vasvi Singh, Marie Foley Kijewski, Frederick L Ruberg

JACC Cardiovasc Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension.
Kevin M Alexander, Margot K Davis, Olakunle Akinboboye, John Berk, Kunal Bhatt, Frederick L Ruberg

JAMA Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool.
Jeremy A Slivnick, Will Hawkes, Jorge Oliveira, Gary Woodward, Ashley Akerman, Frederick L Ruberg

Eur Heart J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure.
Frederick L Ruberg, Sergio Teruya, Stephen Helmke, Dia A Smiley, Denise Fine

JAMA Cardiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Implications of the P.V142I TTR Variant: Insights From CARS.
Isabel R Wees, Colby Ayers, Frederick L Ruberg, Mathew S Maurer, Yevgeniy Brailovsky

JACC Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance.

J Am Coll Cardiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis From ATTRibute-CM.
Ahmad Masri, Daniel P Judge, Frederick L Ruberg, Julian D Gillmore, Justin L Grodin

J Am Coll Cardiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Intensity Exercise, Fibrosis, and Ventricular Arrhythmias: How Much Is Too Much?
Katie J McMenamin, Frederick L Ruberg

Circ Cardiovasc Imaging· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Literacy and Physical Function Among Older Black and Hispanic Individuals With Heart Failure.
Shabatun J Islam, Sergio Teruya, Denise Fine, Natalia Sabogal, Sergylensky Fils, Frederick L Ruberg

J Card Fail· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal global longitudinal strain and reduced serum inflammatory markers in cardiac AL amyloidosis patients without significant amyloid fibril deposition.
Camille V Edwards, Grace M Ferri, Josue Villegas-Galaviz, Sabrina Ghosh, Pushpinder Singh Bawa, Frederick L Ruberg

Amyloid· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis: Proceedings of the Amyloidosis Forum.
Sharmila Dorbala, Rosalyn Adigun, Kevin M Alexander, Michela Brambatti, Sarah A M Cuddy, Frederick L Ruberg

JACC Cardiovasc Imaging· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spinal amyloid deposits are common among older patients undergoing spinal stenosis decompression surgery.
Avni Madhani, Navya Kotturu, Denise Fine, Rabah Alreshq, Aziz Saade, Frederick L Ruberg

J Gen Fam Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Landscape of Therapies for Transthyretin Amyloid Cardiomyopathy.
Jan M Griffin, Justin L Grodin, Frederick L Ruberg, Ahmad Masri, Mazen Hanna

JACC Heart Fail· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Transthyretin as a Biomarker of Treatment Response in ATTR Cardiomyopathy.
Jessica A Regan, Michelle M Kittleson, Michel G Khouri, Frederick L Ruberg, Senthil Selvaraj

J Am Coll Cardiol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Vutrisiran on Functional Capacity and Quality of Life in ATTR Cardiomyopathy: HELIOS-B Analysis.
Omar K Siddiqi, Frederick L Ruberg, Deepa M Gopal

J Am Coll Cardiol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Active Ascertainment on Sex-Specific Differences in the Prevalence and Phenotype of Transthyretin Cardiac Amyloidosis: The Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations Study.
Nicholas Chan, Andrew J Einstein, Sergio Teruya, Carlos Rodriguez, Stephen Helmke, Frederick L Ruberg

Am J Cardiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Outpatient Worsening Heart Failure Serve as an Endpoint in Clinical Trials of Transthyretin Amyloidosis?
Richard K Cheng, Douglas Leedy, Frederick L Ruberg

J Am Coll Cardiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Association of Transthyretin Stability with Variant and Wild-Type Transthyretin Amyloid Cardiomyopathy: The SCAN-MP Study.
Manuel Urina-Jassir, Sergio Teruya, William S Blaner, Pierre-Jacques Brun, Tatiana Prokaeva, Frederick L Ruberg

JACC Heart Fail· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Status and Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes, and Outcomes.
Olivier F Clerc, Shilpa Vijayakumar, Sarah A M Cuddy, Giada Bianchi, Jocelyn Canseco Neri, Frederick L Ruberg

JACC Heart Fail· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlocking Diversity in Cardiovascular Clinical Research: Lessons from the Screening for Cardiac Amyloidosis With Nuclear Imaging in a Minority Populations Study.
Abdirahman Wardhere, Dimitrios Bampatsias, Elizabeth Cohn, Denise Fine, Cinthia de Freitas, Frederick L Ruberg

J Card Fail· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myocardial Characteristics, Cardiac Structure, and Cardiac Function in Systemic Light-Chain Amyloidosis.
Olivier F Clerc, Sarah A M Cuddy, Michael Jerosch-Herold, Dominik C Benz, Ethan Katznelson, Frederick L Ruberg

JACC Cardiovasc Imaging· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mosaic Loss of the Y Chromosome Is Enriched in Patients With Wild-Type Transthyretin Cardiac Amyloidosis and Associated With Increased Mortality.
Mark C Thel, Jesse D Cochran, Sergio Teruya, Ou Hayashi, Christopher R Xie, Frederick L Ruberg

Circ Heart Fail· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Left Ventricular F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis.
Olivier F Clerc, Yesh Datar, Sarah A M Cuddy, Giada Bianchi, Alexandra Taylor, Frederick L Ruberg

JACC Cardiovasc Imaging· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings.
Mathew S Maurer, Prem Soman, Adrian Hernandez, Pablo Garcia-Pavia, James Signorovitch, Frederick L Ruberg

Adv Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of left ventricular systolic dysfunction in light chain amyloidosis: a multiparametric cardiac MRI study.
Ethan Katznelson, Michael Jerosch-Herold, Sarah A M Cuddy, Olivier F Clerc, Dominik C Benz, Frederick L Ruberg

Front Cardiovasc Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis